UC HEALTH LINE: Implantable Birth Control New Option for Women
CINCINNATIA single-rod implantable contraceptive that has been available in other countries since 1998 is now being used in the United States, including in the Cincinnati area.
The implant is injected underneath the skin of the upper arm during an in-office procedure that takes about one minute. The implant, the size of a matchstick, releases a steady stream of the female hormone etonogestrel (Implanon) over a three-year period.
This is a great option for women who cant take pills or dont easily tolerate other birth control options like IUDs and the patch, says University of Cincinnati (UC) fertility expert and contraceptive researcher Michael Thomas, MD.
Etonogestrel works by thickening the cervical mucus, which prevents sperm from fertilizing an egg and also stops any egg that does get fertilized from implanting itself in the uterine wall. Etonogestrel completely inhibits the release of eggs from the ovaries during the first two years. In the third year, it begins to lose its effectiveness.
Women who use this form of birth control dont have to worry about taking a pill every day or changing their birth control ring every month, says Thomas. Its a great long-term option.
Thomas cautions, however, that the implant is not for everyone. Unfortunately, irregular bleeding is a side effect. Women have to be willing to tolerate this possibility. Also, women who experience heavy bleeding or are significantly overweight may want to consider other birth control options.
Thomas is a physician with UCs Center for Reproductive Health, which has expertise in infertility, menopause and endocrinological disorders. Established in 1988, its the only comprehensive patient care and research unit focused on womens health in the
Thomas has no financial interest in Organon
Michael Thomas, MD, shows the matchstick size implantable birth control now available for women.
Tags
Related Stories
The biggest skin-care trends of 2026 go back to basics
January 8, 2026
The University of Cincinnati's Kelly Dobos was featured in an Allure article discussing the biggest skin-care trends of 2026.
What's behind the mysterious rise of migraines?
January 5, 2026
Weather patterns such as extreme heat and storm conditions have been linked to migraine attacks, and research shows those environmental conditions are becoming more common. As National Geographic recently reported, one of the leading theories behind this mysterious rise is that climate change may be playing a role.
Top six 2025 nephrology drug approvals
January 5, 2026
“2025 has been a landmark year for kidney disease therapeutics, marked by a comprehensive slate of FDA approvals covering endothelin-receptor blockade, complement inhibition, GLP-1-based metabolic protection, and B-cell-directed therapy,” Prakash Gudsoorkar, MD, associate professor of clinical medicine at the University of Cincinnati College of Medicine and staff nephrologist at UC Health, recently told MedCentral.